SCHEMBL21886863

SCHEMBL21886863

CCOc1ccc(N)c(C#N)c1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 1/20 0.44
KDM4E B2RXH2 8/20 0.43
MAPT P10636 7/20 0.43
HPGD P15428 7/20 0.43
ALDH1A1 P00352 5/20 0.43
HSD17B10 Q99714 5/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
MAPK1 P28482 4/20 0.43
POLB P06746 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 7/20 0.41
NPSR1 Q6W5P4 4/20 0.41
ALOX12 P18054 1/20 0.41
HTT P42858 1/20 0.41
ALOX15 P16050 4/20 0.40
BRCA1 P38398 2/20 0.40
USP2 O75604 2/20 0.40
PRNP P04156 1/20 0.40
CASP1 P29466 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21808034 0.81 ALDH1A1 (0.44) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL28114068 0.80 HPGD (0.41) PDE3AKDM4EMAPTHPGDALDH1A1
SCHEMBL2416172 0.76 ALDH1A1 (0.58) PDE3AKDM4EMAPTHPGDALDH1A1
SCHEMBL9929711 0.76 MEN1 (0.42) PDE3AKDM4EMAPTHPGDALDH1A1
SCHEMBL27926958 0.69 ALDH1A1 (0.64) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL23087507 0.69 PDE3A (0.43) PDE3AKDM4EMAPTHPGDALDH1A1
SCHEMBL31431229 0.69 MAPT (0.59) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL14150626 0.69 TRPV4 (0.53) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL23948615 0.68 MEN1 (0.41) PDE3AKDM4EMAPTHPGDALDH1A1
SCHEMBL31503799 0.67 KDM4E (0.44) KDM4EMAPTHPGDALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020057511-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS SUZHOU ZANRONG PHARMA LIMITED (CN) 2020-03-26 WO disclosed